[
  {
    "uuid": "6ff03351f04b5e3c7c48d63f889993c53559e43b",
    "url": "https://www.catholic.org/news/hf/faith/story.php?id=86885",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Deacon Frederick Bartels",
    "published": "2023-12-29T05:00:00Z",
    "title": "Ring in the New Year with Mary, the Mother of God",
    "text": "Ring in the New Year with Mary, the Mother of God\nFREE Catholic Classes\nRinging in the new year is part of our national pastime. But why do we do it? Is it simply about having fun? Or is there a deeper meaning found in this practice, one which echoes from the depths of the human heart?\nHi readers, it seems you use Catholic Online a lot; that's great! It's a little awkward to ask, but we need your help. If you have already donated, we sincerely thank you. We're not salespeople, but we depend on donations averaging $14.76 and fewer than 1% of readers give. If you donate just $5.00, the price of your coffee, Catholic Online School could keep thriving. Thank you.\nWe ask you, humbly: don't scroll away. Help Now >\nPhoto credit: Annie Spratt\nHighlights\nDeacon Frederick Bartels\n12/29/2023 (45 minutes ago)\nPublished in\nLiving Faith\nKeywords:\nNew Year, Mary, Mother of God\nWhile the secular world bids adieu to the old year and rings in the new with parties and pledges of well-meaning new year's resolutions, the Church calls the attention of Christians to the mother of Jesus with the January 1st Solemnity of the Blessed Virgin Mary, the Mother of God.\nPlease don't misunderstand. Celebrating the new year with friends, conversation, and fun is fineâ€\"nothing wrong with that. Even more, positive new year's resolutions to live one's life better are ... well ... even better. I have fond memories as a young man, happily married to my wonderful wife, of staying up late, spending time with friends, and setting off fireworks at midnight as we jovially looked forward to the year to come.\nIt seems to me, however, given the past few years and the diminishing state of our nation, that celebrating the new year has taken on a new tone and urgency. Americans and others around the world have grown quite tiredâ€\"to say the leastâ€\"of the agendas foisted on us by globalists and secular elites.\nWe've endured the destruction of businesses, the shutdown of the economy, psychological damage, forced \"vaccinations,\" the insanity of masking children and stunting their learning development, leftist cancel culture, techno-tyranny, and misinformation guardiansâ€\"all with the purported (tyrannical) aim of \"protecting us.\"\nWe're disgusted and justly angered by the mire of lies in the political realm and from government controlled news media. We're fed up with the indoctrination of our children in public schools, colleges, and universities. We're enraged by the cry, \"My body, my choice,\" which is about one person choosing to kill and discard an innocent child. We've had it with \"trans library days\" and \"diversity, equity, and inclusion training.\" Not to mention the war currently waged on marriage and family with a whole host of other evils.\nThe fact is, the enemies of mankind have shown their hand and awakened the people to their evil designs. Just as Satan always overplays his hand, so too have those who desire to reduce the population and enslave those who survive in 15-minute-cities and with carbon credit scores.\nGiven all of that, we know that good will prevail over evil. Justice will reign. We can and will make positive changes. The average hard-working American who wants to raise a family and build a future for his children will win out in the end. Perhaps ringing in this new year is very much about that kind of hope for the future.\n[]https://www.youtube.com/watch?v=V-q5SzwJyi4\nUnderstanding the birth of Jesus Christ\nSpeakin' with the Deacons\nLive Wednesday 12/20 @ 10am PDT\nJoin US LIVE on YouTube\nThe Fulfillment of our DesiresAnd yet there's something more going on. While it's true that in each of us resides the hope that we can make a better future for ourselves, our families, and others, if we look more closely, we find there's a deeper meaning at the foundation of the desire to ring in the new year. It's not so much about the immediate future as the long term future.\nEvery human person, without exception, wants to be happy. But what is the source of this desire? It's rooted in our desire for God, for he has made us for himself, and it is God alone who can provide the perfect happiness and fulfillment for which all of us yearn.\nIf people think the new year is all about a new beginning in the world, it is but a dim shadow of the reality set before us, made possible by Mary's fiat, her \"yes\" to the Angel Gabriel's invitation to accept God's plan for her to bear forth the Savior of the world.\nThe point is, there's nothing as exciting as the \"new year\" in God's planâ€\"the new beginning set before us in Christ, as St. Paul tells us:\nWhen the fullness of time had come, God sent his Son, born of a woman, born under the law, to ransom those under the law, so that we might receive adoption as sons. As proof that you are sons, God sent the Spirit of his Son into our hearts, crying out, \"Abba, Father!\" So you are no longer a slave but a son, and if a son then also an heir, through God. (Gal 4:4-7)\nAnd again as St. John teaches:\nFor God so loved the world that he gave his only Son, that whoever believes in him should not perish but have eternal life. For God sent the Son into the world, not to condemn the world, but that the world might be saved through him. (John 3:16-17)\nChrist defeats our Greatest Enemies\nGod sent his Son Jesus, born of the Virgin Mary, to ransom mankind from sin, evil, and the eternal death of the soul. By virtue of faith in Christ, his sacrifice on the cross, and the grace of the Holy Spirit, we are freed from our greatest enemies. Consequently, we are children of God the Father and heirs to his everlasting kingdom of joy, peace, and fulfillment.\nFREE Catholic Classes Pick a class, you can learn anything\nThis constitutes a free and unmerited gift of love from God, a truly new beginning for each and every one of usâ€\"one which was made possible by the Virgin Mary and her \"yes\" to cooperate with the Father's plan and bear forth Jesus of Nazareth, the Savior and Redeemer. We should guard this new beginning tightly in our heart, look forward to it in hope, and live our life with it in mind.\nA Spiritually Fruitful New Year\nDo you want to make this new year as spiritually fruitful as possible? Is the true \"new year\" and new beginning the focus of your hope? If the answer is \"yes,\" it must begin by pondering the mysteries of Christ in your heart, as did Mary (Luke 2:19, 51). It consists in listening to Christ and opening the door of your mind and heart to him: \"Behold, I stand at the door and knock; if any one hears my voice and opens the door, I will come in to him and eat with him, and he with me\" (Rev 3:20).\nIt is found in entrusting yourself to Christ and living your life in him, that you may have life everlasting, for our Lord said, \"I am the resurrection and the life; he who believes in me, though he die, yet shall he live, and whoever lives and believes in me shall never die\" (John 11:25-26).\nIt means seeking the truth, falling in love with it, and living it out, for Christ said, \"For this I was born, and for this I have come into the world, to bear witness to the truth. Every one who is of the truth hears my voice\" (John 18:37), and \"If you continue in my word, you are truly my disciples, and you will know the truth, and the truth will make you free\" (John 8:31-32).\nIn a word, it's about love for Christ and keeping his commandments: \"If a man loves me, he will keep my word, and my Father will love him, and we will come to him and make our home with him\" (John 14:23).\nThat, my friends, is truly the new beginning. It is the everlasting new year!\nJoin the Movement\nWhen you sign up below, you don't just join an email list - you're joining an entire movement for Free world class Catholic education.\n-\n-\nMysteries of the Rosary\n-\nSt. Faustina Kowalska\n-\nLitany of the Blessed Virgin Mary\n-\nSaint of the Day for Wednesday, Oct 4th, 2023\n-\nPopular Saints\n-\nSt. Francis of Assisi\n-\nBible\n-\nFemale / Women Saints\n-\n7 Morning Prayers you need to get your day started with God\n-\nLitany of the Blessed Virgin Mary\nCatholic PDFs - Print - Free Light a Virtual Prayer Candle\nDaily Catholic\nDaily Readings for Saturday, December 30, 2023 St. Anysia: Saint of the Day for Saturday, December 30, 2023 St. Theresa of the Child Jesus: Prayer of the Day for Saturday, December 30, 2023 Daily Readings for Friday, December 29, 2023 St. Aileran: Saint of the Day for Friday, December 29, 2023 I Came to You Late: Prayer of the Day for Friday, December 29, 2023\nSaints & Angels\nPrayers\nCopyright 2023 Catholic Online. All materials contained on this site, whether written, audible or visual are the exclusive property of Catholic Online and are protected under U.S. and International copyright laws, © Copyright 2023 Catholic Online. Any unauthorized use, without prior written consent of Catholic Online is strictly forbidden and prohibited.\nCatholic Online is a Project of Your Catholic Voice Foundation, a Not-for-Profit Corporation. Your Catholic Voice Foundation has been granted a recognition of tax exemption under Section 501(c)(3) of the Internal Revenue Code. Federal Tax Identification Number: 81-0596847. Your gift is tax-deductible as allowed by law.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "Social Issue",
      "Religion and Belief"
    ],
    "external_links": [
      "https://ycvf.org/products/donate?utm_campaign=Catholic%20Online%20Ads&utm_source=Top%20Ad&utm_medium=We%20Humbly_orangeBlue",
      "http://www.youtube.com/watch?v=V-q5SzwJyi4",
      "https://prayercandles.org/",
      "https://www.catholiconline.school/?utm_source=Catholic%20Online&utm_medium=Under%20Page%20Title&utm_campaign=The%20%231%20Catholic%20Online%20School&utm_content=FREE%20Catholic%20Classes",
      "https://catholicresources.education/",
      "https://catholicresources.education",
      "https://www.catholicresources.education/",
      "http://youtube.com/watch?v=V-q5SzwJyi4",
      "https://ycvf.org/products/donate",
      "https://www.catholiconline.school/",
      "https://prayercandles.org",
      "https://www.prayercandles.org/",
      "https://www.ycvf.org/products/donate?utm_campaign=Catholic%20Online%20Ads&utm_source=Top%20Ad&utm_medium=We%20Humbly_orangeBlue",
      "http://www.youtube.com/watch",
      "https://catholiconline.school/?utm_source=Catholic%20Online&utm_medium=Under%20Page%20Title&utm_campaign=The%20%231%20Catholic%20Online%20School&utm_content=FREE%20Catholic%20Classes"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "mother of god ring",
          "sentiment": "neutral"
        },
        {
          "name": "mary",
          "sentiment": "neutral"
        },
        {
          "name": "mother of god",
          "sentiment": "neutral"
        },
        {
          "name": "annie spratt",
          "sentiment": "none"
        },
        {
          "name": "jesus",
          "sentiment": "none"
        },
        {
          "name": "frederick bartels",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "church",
          "sentiment": "none"
        },
        {
          "name": "catholic online school",
          "sentiment": "none"
        },
        {
          "name": "catholic online",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "rating": null,
    "crawled": "2023-12-29T18:29:41.399+02:00",
    "updated": "2023-12-29T18:29:41.399+02:00"
  },
  {
    "uuid": "2759494d9f243ad68073aec696e5620a51f1f0dc",
    "url": "https://www.informador.mx/estilo/Salud-Esta-es-la-fruta-que-ayuda-a-prevenir-enfermedades-cronicas-20240404-0112.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "CMS Medios",
    "published": "2024-04-04T22:05:00Z",
    "title": "Salud: Esta es la fruta que ayuda a prevenir enfermedades crónicas | El Informador",
    "text": "Las frutas y verduras son los alimentos más recomendados para la salud gracias a su alto contenido en minerales, vitaminas, nutrientes y demás propiedades que ayudan a fortalecer el sistema inmunológico de las personas.Además del consumo de estos alimentos, se recomienda complementar con una rutina de ejercicio, dando así una de las recetas más eficaces para prevenir muchas cantidades de dolencias y afecciones, así como de enfermedades crónicas.El Instituto Mayo Clinic afirma que existen varios cambios en el estilo de vida que se pueden implementar para reducir el riesgo de padecer enfermedades crónicas. En este marco, señala que es fundamental mantenerse en un peso saludable, ingerir alimentos saludables, hacer ejercicio regularmente y dejar de fumar. Además, recomienda la consulta periódica con nuestro médico de cabecera para poder controlar adecuadamente nuestra salud.Al respecto, hoy te presentamos al mango, una poderosa fruta tropical que por sus propiedades reduce el riesgo de enfermedades crónicas. Desde el Centro de Investigación en Alimentación y Desarrollo en Hermosillo, han dado a conocer a través de un estudio todos los beneficios que se pueden encontrar en este alimento.La nutricionista Laura A. de la Rosa, a cargo del estudio señalado, destaca al consumo regular de esta fruta como muy positiva para la prevención de enfermedades como diabetes, cáncer y afecciones cardíacas. Esto se debe a que el mango es un alimento que contiene altos porcentajes de antioxidantes (polifenoles y carotenoides) que se encargan de combatir la inflamación y el estrés oxidativo.Además, esta fruta aporta vitaminas A y C, por lo que refuerza el sistema inmunológico, estimula la producción de colágeno para la piel y protege nuestros ojos de la luz solar. Además, su contenido de fibra mejora la digestión y los ácidos grasos Omega 3 y Omega 6 que suma a nuestro organismo ayudan a reducir los niveles del denominado colesterol malo.Por todo lo señalado, no hay dudas de que el mango es un alimento que podemos sumar como un gran aliado para el cuidado de nuestra salud.JV",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "positive",
    "categories": [
      "Health"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-04-05T01:08:51.919+03:00",
    "updated": "2024-04-05T01:08:51.919+03:00"
  },
  {
    "uuid": "9bc1b48aa67840943691fd6bf8e23561de588ec4",
    "url": "https://hardwareand.co/actualites/breves/c-est-officiel-pas-de-rtx-5070-ti-founders-edition-chez-nvidia",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "David Sergent",
    "published": "2025-01-10T09:04:00Z",
    "title": "C'est officiel, pas de RTX 5070 Ti Founders Edition chez NVIDIA - Hardware & Co",
    "text": "Si vous êtes plutôt un amateur du design des cartes graphiques 100 % d'origine NVIDIA, avec le design maison baptisé \"Founders Edition\", sachez que toute la gamme GeForce RTX 50 ne sera malheureusement pas déclinée en version FE. Une référence en particulier n'a pas été élue : la RTX 5070 Ti. Il en existe en réalité une seconde, mais qui nous concerne moins en France : la RTX 5090 D. Pour ceux qui ne seraient pas trop au fait de l'existence de cette dernière, il s'agit d'une carte aux caractéristiques totalement identiques à celles de la RTX 5090 à un détail près : une castration au niveau des Tensor Cores afin de diminuer ses performances en calcul IA, et ainsi passer sous le niveau maximum de performances toléré par les États-Unis pour autoriser une vente à la Chine. Ainsi, la RTX 5090 D est tout simplement la version chinoise de la RTX 5090, et elle aussi ne proposera donc pas de design de référence Founders Edition.\nLe schéma est donc parfaitement identique à celui existant pour les GeForce RTX 40, mais c'est dans la réalisation des designs FE que les choses ont bien changé. Avec son design à multiples PCB, NVIDIA est parvenu à faire des GeForce RTX 5090 FE et GeForce RTX 5080 FE double slot, faisant donc seulement 4 cm d'épaisseur quand les GeForce RTX 4090 FE et GeForce RTX 4080 (SUPER) FE étaient toutes en triple slot. Rappelons de plus que les RTX 5090 et RTX 5080 consomment pourtant plus que leurs ainées, une excellente nouvelle donc pour ceux qui n'ont pas énormément de place dans leur boitier, même s'il faudra maintenant attendre les tests pour vérifier si tout cela ne se paie pas au prix de nuisances sonores supérieures sur la nouvelle génération.\nNous vous proposons pour finir cette actualité un petit tour d'horizon, en guise de rappel, des différentes cartes NVIDIA Founders Edition et ce pour toutes les générations de cartes graphiques GeForce RTX sorties jusqu'à présent. Nous avons précisé les dimensions des cartes et leurs consommations.\nGeForce RTX 50 | Founders Edition | Longueur | Hauteur | Épaisseur | Consommation |\n---|---|---|---|---|---|\nRTX 5090 | oui | 304 mm | 137 mm | 2 slots | 575 W |\nRTX 5090 D | non | x | x | x | x |\nRTX 5080 | oui | 304 mm | 137 mm | 2 slots | 360 W |\nRTX 5070 Ti | non | x | x | x | x |\nRTX 5070 | oui | 242 mm | 112 mm | 2 slots | 250 W |\nGeForce RTX 40 | Founders Edition | Longueur | Hauteur | Épaisseur | Consommation |\n---|---|---|---|---|---|\nRTX 4090 | oui | 304 mm | 137 mm | 3 slots | 450 W |\nRTX 4090 D | non | x | x | x | x |\nRTX 4080 SUPER | oui | 304 mm | 137 mm | 3 slots | 320 W |\nRTX 4080 | oui | 304 mm | 137 mm | 3 slots | 320 W |\nRTX 4070 Ti SUPER | non | x | x | x | x |\nRTX 4070 Ti | non | x | x | x | x |\nRTX 4070 SUPER | oui | 244 mm | 112 mm | 2 slots | 200 W |\nRTX 4070 | oui | 244 mm | 112 mm | 2 slots | 200 W |\nRTX 4060 Ti | oui | 244 mm | 98 mm | 2 slots | 165/160 W |\nRTX 4060 | non | x | x | x | x |\nGeForce RTX 30 | Founders Edition | Longueur | Hauteur | Épaisseur | Consommation |\n---|---|---|---|---|---|\nRTX 3090 Ti | oui | 313 mm | 138 mm | 3 slots | 450 W |\nRTX 3090 | oui | 313 mm | 138 mm | 3 slots | 350 W |\nRTX 3080 Ti | oui | 285 mm | 112 mm | 2 slots | 350 W |\nRTX 3080 | oui | 285 mm | 112 mm | 2 slots | 350/320 W |\nRTX 3070 Ti | oui | 267 mm | 112 mm | 2 slots | 290 W |\nRTX 3070 | oui | 242 mm | 112 mm | 2 slots | 220 W |\nRTX 3060 Ti | oui | 242 mm | 112 mm | 2 slots | 200 W |\nRTX 3060 | non | x | x | x | x |\nRTX 3050 8 Go | non | x | x | x | x |\nRTX 3050 6 Go | non | x | x | x | x |\nGeForce RTX 20 | Founders Edition | Longueur | Hauteur | Épaisseur | Consommation |\n---|---|---|---|---|---|\nRTX 2080 Ti | oui | 267 mm | 116 mm | 2 slots | 260 W |\nRTX 2080 SUPER | oui | 267 mm | 116 mm | 2 slots | 250 W |\nRTX 2080 | oui | 267 mm | 116 mm | 2 slots | 225 W |\nRTX 2070 SUPER | oui | 267 mm | 116 mm | 2 slots | 215 W |\nRTX 2070 | oui | 228 mm | 113 mm | 2 slots | 185 W |\nRTX 2060 SUPER | oui | 228 mm | 113 mm | 2 slots | 175 W |\nRTX 2060 | oui | 228 mm | 113 mm | 2 slots | 185/160 W |",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "french",
    "sentiment": "negative",
    "categories": [
      "Science and Technology"
    ],
    "topics": [
      "Science and Technology->technology and engineering"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": null,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2025-01-10T11:32:49.247+02:00",
    "updated": "2025-01-11T09:01:12.299+02:00"
  },
  {
    "uuid": "cfc1445e184310b6a957013465b852189dc134d4",
    "url": "https://www.stocktitan.net/news/PCRX/pacira-bio-sciences-acquires-remaining-equity-stake-of-gq-7pzvf6djz0q8.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "StockTitan",
    "published": "2025-02-27T21:00:00Z",
    "title": "How Pacira's $32M GQ Bio Acquisition Transforms Its Gene Therapy Strategy",
    "text": "Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio\nPacira BioSciences (PCRX) has acquired the remaining 81% equity stake in GQ Bio Therapeutics for approximately $32 million. The transaction includes $18 million paid at closing, $8 million over three years for key employee retention, and a $6 million post-closing indemnity holdback.\nThe acquisition strengthens Pacira's '5x30' strategy to become an innovative biopharmaceutical organization, adding GQ Bio's high-capacity adenovirus (HCAd) gene therapy vector platform. This platform enables efficient genetic medicines delivery and supports multiple gene constructs, particularly focusing on musculoskeletal diseases.\nThe deal eliminates Pacira's future milestone payment obligations of up to $64 million, including a $4.5 million payment due for PCRX-201's Phase 2 clinical trial initiation. Pacira plans to maintain GQ Bio's operations and invest in the HCAd platform, leveraging its clinical, regulatory, and commercial capabilities to address chronic pain conditions affecting nearly 1 in 4 Americans.\nPacira BioSciences (PCRX) ha acquisito la restante partecipazione azionaria dell'81% in GQ Bio Therapeutics per circa 32 milioni di dollari. La transazione include 18 milioni di dollari pagati al momento della chiusura, 8 milioni di dollari distribuiti su tre anni per la retention dei dipendenti chiave, e un'indennità di 6 milioni di dollari trattenuta post-chiusura.\nL'acquisizione rafforza la strategia '5x30' di Pacira per diventare un'organizzazione biopharmaceutica innovativa, aggiungendo la piattaforma di vettori per terapia genica ad adenovirus ad alta capacità (HCAd) di GQ Bio. Questa piattaforma consente una consegna efficiente dei medicinali genetici e supporta molteplici costrutti genici, concentrandosi in particolare sulle malattie muscoloscheletriche.\nIl contratto elimina le future obbligazioni di pagamento di milestone di Pacira fino a 64 milioni di dollari, incluso un pagamento di 4,5 milioni di dollari dovuto per l'inizio della fase 2 della sperimentazione clinica di PCRX-201. Pacira prevede di mantenere le operazioni di GQ Bio e investire nella piattaforma HCAd, sfruttando le proprie capacità cliniche, regolatorie e commerciali per affrontare le condizioni di dolore cronico che colpiscono quasi 1 americano su 4.\nPacira BioSciences (PCRX) ha adquirido el restante 81% de participación en GQ Bio Therapeutics por aproximadamente 32 millones de dólares. La transacción incluye 18 millones de dólares pagados al cierre, 8 millones de dólares durante tres años para la retención de empleados clave, y un retención de indemnización de 6 millones de dólares después del cierre.\nLa adquisición refuerza la estrategia '5x30' de Pacira para convertirse en una organización biofarmacéutica innovadora, añadiendo la plataforma de vectores de terapia génica de adenovirus de alta capacidad (HCAd) de GQ Bio. Esta plataforma permite una entrega eficiente de medicamentos genéticos y soporta múltiples construcciones genéticas, enfocándose particularmente en enfermedades musculoesqueléticas.\nEl acuerdo elimina las futuras obligaciones de pago de hitos de Pacira de hasta 64 millones de dólares, incluyendo un pago de 4.5 millones de dólares debido por el inicio del ensayo clínico de fase 2 de PCRX-201. Pacira planea mantener las operaciones de GQ Bio e invertir en la plataforma HCAd, aprovechando sus capacidades clínicas, regulatorias y comerciales para abordar las condiciones de dolor crónico que afectan a casi 1 de cada 4 estadounidenses.\nPacira BioSciences (PCRX)는 GQ Bio Therapeutics의 남은 81% 지분을 약 3200만 달러에 인수했습니다. 이 거래에는 마감 시 1800만 달러 지급, 주요 직원 유지를 위한 3년 동안의 800만 달러, 마감 후 600만 달러의 손해 보전 유보가 포함됩니다.\n이번 인수는 Pacira의 혁신적인 생물 제약 조직이 되기 위한 '5x30' 전략을 강화하며, GQ Bio의 고용량 아데노바이러스(HCAd) 유전자 치료 벡터 플랫폼을 추가합니다. 이 플랫폼은 효율적인 유전자 의약품 전달을 가능하게 하고, 여러 유전자 구조를 지원하며, 특히 근골격계 질환에 집중하고 있습니다.\n이번 거래는 PCRX-201의 2상 임상 시험 시작을 위해 예정된 450만 달러를 포함하여 Pacira의 미래 마일스톤 지급 의무를 최대 6400만 달러까지 없앱니다. Pacira는 GQ Bio의 운영을 유지하고 HCAd 플랫폼에 투자할 계획이며, 만성 통증 상태에 영향을 미치는 미국인 4명 중 1명에 대한 임상, 규제 및 상업적 역량을 활용할 것입니다.\nPacira BioSciences (PCRX) a acquis la participation restante de 81 % dans GQ Bio Therapeutics pour environ 32 millions de dollars. La transaction comprend 18 millions de dollars payés à la clôture, 8 millions de dollars répartis sur trois ans pour la rétention des employés clés, et une retenue d'indemnité de 6 millions de dollars après la clôture.\nL'acquisition renforce la stratégie '5x30' de Pacira pour devenir une organisation biopharmaceutique innovante, ajoutant la plateforme de vecteurs de thérapie génique à adénovirus à haute capacité (HCAd) de GQ Bio. Cette plateforme permet une livraison efficace des médicaments génétiques et prend en charge plusieurs constructions génétiques, en se concentrant particulièrement sur les maladies musculosquelettiques.\nL'accord élimine les obligations de paiement de jalons futurs de Pacira pouvant atteindre 64 millions de dollars, y compris un paiement de 4,5 millions de dollars dû pour le début de l'essai clinique de phase 2 de PCRX-201. Pacira prévoit de maintenir les opérations de GQ Bio et d'investir dans la plateforme HCAd, en tirant parti de ses capacités cliniques, réglementaires et commerciales pour traiter les conditions de douleur chronique affectant près d'un Américain sur quatre.\nPacira BioSciences (PCRX) hat die verbleibenden 81% der Anteile an GQ Bio Therapeutics für etwa 32 Millionen Dollar erworben. Die Transaktion umfasst 18 Millionen Dollar, die bei Abschluss gezahlt werden, 8 Millionen Dollar über drei Jahre für die Bindung von Schlüsselmitarbeitern und eine Rücklage von 6 Millionen Dollar nach dem Abschluss.\nDie Übernahme stärkt Paciras '5x30'-Strategie, um eine innovative biopharmazeutische Organisation zu werden, und fügt die Hochkapazitäts-Adenovirus (HCAd) Gentherapie-Vektorplattform von GQ Bio hinzu. Diese Plattform ermöglicht eine effiziente Lieferung genetischer Medikamente und unterstützt mehrere Genkonstrukte, wobei der Fokus insbesondere auf muskuloskelettalen Erkrankungen liegt.\nDer Deal beseitigt Paciras zukünftige Verpflichtungen zur Zahlung von Meilensteinzahlungen von bis zu 64 Millionen Dollar, einschließlich einer Zahlung von 4,5 Millionen Dollar, die für den Beginn der Phase-2-Studie von PCRX-201 fällig ist. Pacira plant, die Geschäfte von GQ Bio aufrechtzuerhalten und in die HCAd-Plattform zu investieren, um ihre klinischen, regulatorischen und kommerziellen Fähigkeiten zu nutzen, um chronische Schmerzbedingungen zu adressieren, die fast 1 von 4 Amerikanern betreffen.\n- Eliminates $64M in future milestone payment obligations\n- Acquires valuable HCAd gene therapy platform\n- Expands preclinical portfolio in musculoskeletal diseases\n- PCRX-201 shows encouraging clinical data in osteoarthritis\n- Strengthens R&D capabilities with additional talent\n- $32M cash outlay impacts immediate financial position\n- $8M additional payment commitment over next 3 years\nInsights\nPacira BioSciences' acquisition of the remaining 81% equity stake in GQ Bio for\nThe acquisition represents vertical integration of a technology Pacira was already invested in, as evidenced by the PCRX-201 program for osteoarthritis which recently advanced to Phase 2 trials. By bringing the HCAd gene therapy platform fully in-house, Pacira gains complete control over its development pipeline while avoiding the\nThis transaction accelerates Pacira's \"5x30\" strategic transformation from a specialty pharmaceutical company into an innovation-driven biopharmaceutical organization. The HCAd platform's ability to deliver large and multiple gene constructs locally represents a technological differentiator in the competitive landscape of non-opioid pain management, potentially addressing root causes rather than symptoms.\nWith chronic pain affecting\nWhile the transaction appears strategically sound, investors should monitor integration progress, R&D expense trajectory, and clinical development timelines as Pacira works to leverage this platform across multiple musculoskeletal indications and potential partnership opportunities outside its core focus.\nPacira's acquisition of GQ Bio's high-capacity adenoviral (HCAd) vector platform represents a technologically differentiated approach to genetic medicine delivery. Unlike conventional adeno-associated viral (AAV) vectors to ~4.7kb of genetic cargo, HCAd vectors can accommodate up to 36kb of genetic material - allowing delivery of larger therapeutic genes or multiple gene constructs simultaneously, a critical advantage for addressing complex musculoskeletal conditions.\nThe platform's local delivery approach is particularly noteworthy for musculoskeletal applications. By administering genetic payloads directly to affected joints or tissues rather than systemically, this approach potentially mitigates the immunogenicity concerns that have challenged other gene therapy modalities. Local administration may also enable more precise dosing and reduce off-target effects, addressing key safety hurdles that have slowed adoption of genetic medicines.\nPCRX-201's advancement to Phase 2 trials for osteoarthritis represents an important clinical validation milestone. The candidate likely delivers therapeutic genes that modulate inflammatory pathways or stimulate cartilage regeneration - addressing disease biology rather than merely masking symptoms as current treatments do.\nFrom a manufacturing perspective, the HCAd platform could offer scalability advantages over other gene therapy vectors. Adenoviral vectors typically yield higher titers in production systems compared to AAV, potentially reducing manufacturing costs and improving commercial viability.\nThe acquisition positions Pacira competitively against other companies exploring genetic approaches to musculoskeletal conditions, including Flexion Therapeutics (acquired by Pacira in 2021), Bone Therapeutics, and Kolon TissueGene. The full integration of this platform gives Pacira end-to-end control over development, potentially accelerating timelines while reducing dependency on external technology partners.\nWhile promising, investors should recognize the regulatory complexities associated with gene therapy products. Pacira will need to address potential concerns about long-term safety, durability of effect, and manufacturing consistency as programs advance through clinical development.\n-- Advances Pacira’s “5x30” path to becoming an innovative biopharmaceutical organization --\n-- Adds novel, high-capacity, local-delivery platform for the development of genetic medicines with disease-modifying potential for prevalent musculoskeletal diseases with significant unmet needs --\n-- Brings preclinical portfolio and research and development talent --\n-- Provides expected near-term and long-term financial benefits with elimination of future milestone payments --\nPARSIPPANY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced it has acquired the remaining 81 percent equity stake of GQ Bio Therapeutics GmbH for approximately\nGQ Bio is a privately held biopharmaceutical company with a novel, high-capacity, local-delivery platform that makes genetic medicines more efficient and enables the use of large and multiple gene constructs. GQ Bio also brings to Pacira a preclinical portfolio of assets with disease-modifying potential in prevalent musculoskeletal diseases, and research and development talent.\n“We are confident that this transaction will enhance our ability to address unmet patient needs, while building on our 5x30 plan to transition into an innovative biopharmaceutical organization,” said Frank D. Lee, chief executive officer of Pacira. “We have seen GQ Bio’s platform generate encouraging clinical data with PCRX-201 in osteoarthritis, underscoring the potential of this novel platform.”\n“Beyond the lead indication in osteoarthritis, we believe the HCAd platform has great potential to solidify Pacira as a leading developer of new treatments for musculoskeletal pain and adjacencies by addressing the underlying cause of chronic pain using a targeted molecular approach. With nearly 1 in 4 Americans currently suffering from chronic pain, there is a critical need to address this national epidemic. Additionally, we see great potential for partnering in areas outside of our therapeutic focus to extend the HCAd platform into other conditions of high unmet need where local administration of a genetic medicine is warranted,” continued Mr. Lee.\nTransaction Details\nPacira intends to maintain GQ Bio’s operations and invest in its HCAd gene therapy vector platform and innovative products built on the platform, leveraging Pacira’s clinical, regulatory and commercial capabilities.\nThe transaction provides Pacira with substantial expected financial benefits by eliminating its obligations for up to\nAbout the HCAd Platform\nGQ Bio’s HCAd vector platform solves many of the challenges in the field of genetic medicine that have prevented its utilization in treating common diseases like osteoarthritis. Key features include:\n- The HCAd vector is much more efficient at delivering genes into cells compared to many other gene therapies that rely on adenovirus associated virus, or AAV, vectors. As a result, the desired effect can be achieved with much smaller doses.\n- The vector used in the HCAd platform can carry up to 30,000 base pairs of DNA, which enables gene therapy with multiple or larger genes compared to AAV vectors.\n- Genetic medicines based on the HCAd platform can be administered locally and have the potential for redosing at therapeutically appropriate intervals.\n- Lower dose levels and efficient delivery of genes into cells means that thousands of doses can be produced in a single batch. As a result, therapies built on the HCAd platform are expected to have a commercially attractive and viable cost of goods profile.\nAbout the HCAd Pipeline\nPacira’s novel product candidate PCRX-201 (enekinragene inzadenovec), originally developed by GQ Bio, features an innovative HCAd-based design. PCRX-201 is in clinical development for osteoarthritis of the knee. PCRX-201 is injected locally into the knee joint to boost cellular production of interleukin-1 receptor antagonist (IL-1Ra) and block IL-1 pathway activation, significantly reducing chronic inflammation. PCRX-201’s unique design also features an inflammation-responsive promoter to only produce IL-1Ra when needed, mimicking how the body naturally responds to inflammation.\nAt the American College of Rheumatology meeting in November 2024, Pacira reported promising data from a large Phase 1 study in which PCRX-201 provided sustained improvements in knee pain, stiffness, and function through two years following local administration, with a well-tolerated safety profile. The Company is preparing to initiate a randomized, double-blind Phase 2 study of PCRX-201 for the treatment of osteoarthritis of the knee which recently opened for enrollment.\nIn addition to preclinical product candidates based on the HCAd vector platform, the two companies have identified numerous well-validated cytokines that could be the basis for additional locally administered genetic therapies using the HCAd platform.\nAbout Pacira\nPacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and iovera®º, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a novel, locally administered gene therapy with the potential to treat large prevalent diseases like osteoarthritis. To learn more about Pacira, visit www.pacira.com.\nAbout GQ Bio Therapeutics GmbH\nGQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany, as well as Eupen and Liège, Belgium. To learn more about GQ Bio, visit www.gq-biotx.com.\nForward-Looking Statements\nAny statements in this press release about Pacira’s future expectations, plans, trends, outlook, projections and prospects, and other statements containing the words “believes,” “anticipates,” “plans,” “estimates,” “expects,” “intends,” “may,” “will,” “would,” “could,” “can” and similar expressions, constitute forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995, including, without limitation, statements related to: ‘5x30’, our growth and business strategy, our future outlook, contributions of new directors and executives, our intellectual property and patent terms, the acquisition of GQ Bio and the anticipated benefits thereof, our growth and future operating results and trends, our strategy, plans, objectives, expectations (financial or otherwise) and intentions, and future financial results and growth potential, including our plans with respect to the repayment of our indebtedness, anticipated product portfolio, development programs, development of products, strategic alliances, and the Non-Opioids Prevent Addiction in the Nation (“NOPAIN”) Act and other statements that are not historical facts. For this purpose, any statement that is not a statement of historical fact should be considered a forward-looking statement. We cannot assure you that our estimates, assumptions and expectations will prove to have been correct. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to, among others: the failure to realize the anticipated benefits and synergies from the acquisition of GQ Bio; the ability to successfully integrate GQ Bio into our existing business; the commercial success of GQ Bio’s high-capacity adenovirus gene therapy vector platform; future opportunities and plans for GQ Bio and its product candidates, including uncertainty of the expected financial performance of GQ Bio and its product candidates; disruption from the acquisition of GQ Bio, making it more difficult to conduct business as usual or maintain relationships with customers, employees or suppliers; the possibility that if we do not achieve the perceived benefits of the transaction as rapidly or to the extent anticipated by financial analysts or investors, the market price of our common stock could decline; risks associated with acquisitions, such as the risk that the acquired businesses will not be integrated successfully, that such integration may be more difficult, time-consuming or costly than expected or that the expected benefits of the transaction will not occur; our manufacturing and supply chain, global and U.S. economic conditions (including inflation and rising interest rates), and our business, including our revenues, financial condition, cash flow and results of operations; the success of our sales and manufacturing efforts in support of the commercialization of EXPAREL, ZILRETTA and iovera°; the rate and degree of market acceptance of EXPAREL, ZILRETTA and iovera°; the size and growth of the potential markets for EXPAREL, ZILRETTA and iovera° and our ability to serve those markets; our plans to expand the use of EXPAREL, ZILRETTA and iovera° to additional indications and opportunities, and the timing and success of any related clinical trials for EXPAREL, ZILRETTA and iovera°; the commercial success of EXPAREL, ZILRETTA and iovera°; the related timing and success of U.S. Food and Drug Administration supplemental New Drug Applications and premarket notification 510(k)s; the related timing and success of European Medicines Agency Marketing Authorization Applications; our plans to evaluate, develop and pursue additional product candidates utilizing our proprietary multivesicular liposome (“pMVL”) drug delivery technology; the approval of the commercialization of our products in other jurisdictions; clinical trials in support of an existing or potential pMVL-based product; our commercialization and marketing capabilities; our ability to successfully complete capital projects; the outcome of any litigation; the recoverability of our deferred tax assets; assumptions associated with contingent consideration payments; assumptions used for estimated future cash flows associated with determining the fair value of the Company; the anticipated funding or benefits of our share repurchase program; and factors discussed in the “Risk Factors” of our most recent Annual Report on Form 10-K and in other filings that we periodically make with the Securities and Exchange Commission (the “SEC”). In addition, the forward-looking statements included in this press release represent our views as of the date of this press release. Important factors could cause actual results to differ materially from those indicated or implied by forward-looking statements, and as such we anticipate that subsequent events and developments will cause our views to change. Except as required by applicable law, we undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, and readers should not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.\nThese forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include the matters discussed and referenced in the “Risk Factors” of our most recent Annual Report on Form 10-K and in other filings that we periodically make with the SEC.\nFAQ\nHow much did Pacira BioSciences (PCRX) pay for the remaining stake in GQ Bio?\nWhat technology platform does GQ Bio bring to Pacira (PCRX)?\nHow much will Pacira (PCRX) save in future milestone payments through this acquisition?",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology"
    ],
    "topics": [
      "Health->medical specialisation",
      "Health->health treatment and procedure",
      "Science and Technology->biotechnology",
      "Science and Technology->biomedical science",
      "Science and Technology->scientific innovation"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [
        {
          "name": "GQ Bio Therapeutics",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-02-28T01:25:00.433+02:00",
    "updated": "2025-02-28T01:25:00.433+02:00"
  },
  {
    "uuid": "65c5b664668e9201c7ef5cafe5f485e95f52865f",
    "url": "https://vnexplorer.net/z/1337414.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "VNExplorer",
    "published": "2024-07-12T00:18:00Z",
    "title": "Why Hemant Soren made a swift comeback as Jharkhand CM",
    "text": "In Jharkhand&#039;s turbulent political landscape, Hemant Soren has made a swift rebound to reassert his pivotal position. After securing bail on June 28 in an alleged money-laundering case, Soren wasted no time in resuming his role as chief minister of the state. Soren was reinstated to the post on July 4, with governor C.P. Radhakrishnan administering the oath of office. Champai Soren, who had stepped in as stopgap chief minister following Hemant&#039;s arrest by the Enforcement Directorate (ED) on January 31, gracefully made way. He has been appointed a cabinet minister in the new Jharkhand Mukti Morcha (JMM)-led coalition government, which has Congress and the Rashtriya Janata Dal (RJD) as partners. The new Hemant administration strengthened its position on July 8 by winning the trust vote in the legislative assembly, securing 45 votes in the 81-member House. This marks the ruling coalition&#039;s third government in the current term of the assembly, following their significant victory over the BJP in the November 2019 state election. The second government was formed in February this year when Champai, a senior JMM leader, assumed the role of chief minister after Hemant&#039;s resignation and subsequent arrest. Hemant is back at the helm just as the state begins to pace up for the assembly elections, due in October-November, amidst a dynamic political climate. Many had expected Hemant to allow Champai to continue with the top job till the elections. However, Hemant&#039;s return is a strategic move by the JMM to put its best foot forward in the run-up to the polls. Champai, despite his efforts, lacked the charisma and assertion needed to galvanise support or inspire confidence among party supporters. He was also perceived as somewhat lacking in stature and adequate popularity. Hemant&#039;s return, then, offers the coalition the opportunity to mobilise its vote bases for the forthcoming electoral battle against the BJP. Hemant&#039;s quick return to the political fray also underscores a heightened sense of urgency. The JMM-Congress-RJD alliance faces significant challenges in the upcoming election despite securing all five Scheduled Tribe-reserved seats in the Lok Sabha polls. The BJP-led National Democratic Alliance (NDA) clinching the remaining nine parliamentary seats highlights its enduring influence and support base in the state. For the ruling coalition, the positive takeaways from Hemant&#039;s return are profound: the triumph in tribal strongholds in the Lok Sabha polls not only underscores its dominance among the tribal community but also strategically positions it for the assembly polls. The 28 of Jharkhand&#039;s 81 assembly seats reserved for Scheduled Tribesâover a third of the totalâcan be a key determinant in returning to power. Hemant has already shifted into campaign mode to seize the momentum. Meanwhile, the BJP, reeling from losses in the Scheduled Tribe-reserved Lok Sabha seats, has strategically appointed party stalwart Shivraj Singh Chouhan and Assam chief minister Himanta Biswa Sarma as election in-charges for Jharkhand. Sarma&#039;s engagements with key tribal leaders, including former Union minister Arjun Munda; Sita Soren, MLA and estranged daughter-in-law of JMM chief Shibu Soren; and Geeta Koda on June 29 reflect a concerted effort to bolster appeal among tribal voters. In a state where Scheduled Tribes comprise over 26 per cent of the electorate, their sway cannot be underestimated. The defeat of Munda in the Lok Sabha polls might indirectly benefit the BJP as he can focus on reviving the party&#039;s waning tribal support in Jharkhand. However, the move also risks internal discord, given Munda&#039;s complex equation with BJP state president Babulal Marandi. Hemant&#039;s bail and return as chief minister just ahead of elections may take some sting out of the BJP&#039;s narrative of corruption and lawlessness against the JMM. It may also prompt tribal voters to question the validity of the charges against their chief minister and the integrity of the investigation led by a central agency. The BJP will need to recalibrate its campaign strategy in light of these developments. Hemant&#039;s arrest proved to be a blessing in disguise for his party. During his absence, wife Kalpana Soren emerged as a prominent political figure. Recognised for her eloquence and ability to connect with voters, Kalpana is seen has having significantly bolstered the JMM&#039;s support base, particularly among women and the tribal community. Her active role in the Lok Sabha poll campaign and her decisive victory in the Gandey by-election by a substantial margin of 26,000 votes underscore her burgeoning influence. Hemant&#039;s return as chief minister sets the stage for an electrifying assembly election campaign and an altered political dynamic in Jharkhand. As both coalitions gear up to slug it out, it will be the electorate&#039;s response to unfolding developments that will determine the outcome of what promises to be a crucial and perhaps game-changing election. Subscribe to India Today Magazine Watch Live TV in English Watch Live TV in Hindi",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Politics"
    ],
    "ai_allow": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "hemant soren",
          "sentiment": "negative"
        },
        {
          "name": "champai soren",
          "sentiment": "none"
        },
        {
          "name": "hemant",
          "sentiment": "none"
        },
        {
          "name": "soren",
          "sentiment": "none"
        },
        {
          "name": "c.p. radhakrishnan",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "congress",
          "sentiment": "none"
        },
        {
          "name": "jharkhand mukti morcha",
          "sentiment": "none"
        },
        {
          "name": "bjp",
          "sentiment": "none"
        },
        {
          "name": "house",
          "sentiment": "none"
        },
        {
          "name": "rashtriya janata dal",
          "sentiment": "none"
        },
        {
          "name": "enforcement directorate",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-07-12T11:21:09.750+03:00",
    "updated": "2024-07-12T11:21:09.750+03:00"
  },
  {
    "uuid": "a1d2228bba73c6fe665141d2c3359a778b7bedf7",
    "url": "https://carbuzz.com/news/naturally-aspirated-toyota-ae86-makes-11000-rpm-initial-d-meme-a-reality",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Cesar Miguel",
    "published": "2024-01-06T00:01:00Z",
    "title": "Naturally-Aspirated Toyota AE86 Makes 11,000-RPM 'Initial D' Meme A Reality",
    "text": "Of course, it used the iconic panda colors, too.\nWe all know the 11,000 rpm meme from Initial D, but this AE86 built by Formula Drift OG Taka Aono is the real deal. It was recently shown off at the 2023 SEMA, and while a select few builds, like the\n13k-RPM Mini from hell, can rev beyond that, it's always neat to see screaming monsters like this discussed in detail.\nAs mentioned, this car in question was built by a true fan of the\nToyota AE86. Aono, after all, was the last guy to have used an AE86 in the Formula D series. Larry Chen interviewed him, and the vehicle in question looks like it received heaps of attention and care from its owner and builder. Everything about this ride is immaculate, from the 4AGE inline-4 engine in the engine bay to its body.\nThe engine bay alone is a work of art, but Aono says every part of the car is functional. The 4AGE itself was inspired by Aono's Formula D car. That, however, was noted to be demanding in terms of maintenance, requiring a 24-hour service interval when run with an 11k tune and normal-sized engine internals. Yes, the interval time includes idling time.\nThis new build was reinforced by a newly developed larger crankshaft paired with a much larger set of pistons and a slightly longer block similar to the 2JZ engine, made famous by the fourth-generation A80\nToyota Supra. OS Giken developed these parts and sold them as a kit optimized for strength. This is particularly noteworthy, considering the 4A Toyota engine series was released around 30 years ago.\nOn that end, Aono can reach higher RPMs while having less risk of blowing up. As of the moment, it already makes 170 horsepower to the wheels, which is significant for an engine of this type.\nThen again, the builder/owner says it is currently experiencing issues; its individual throttle bodies are too small. The headers are also experiencing clearance issues with the car's steering shaft.\nOnce those problems are fixed, Aono expects 185-190 hp at the wheels. Still, that doesn't sound much, but he admits he isn't chasing big power. For that, he says he could go the turbocharging route, which he isn't considering now. His priority, after all, is the 11,000 rpm sound.\nOf course, Aono's AE86 also gets the recognizable black-and-white color scheme from the anime. It also rocks a set of RS Watanabe Eight Spoke F8-Type wheels and a carbon fiber hood, among other clean touches. Its interior comprises brand-new, genuine Toyota parts except for the Bride bucket seats, carbon fiber cash, and interior door panels. Oh, and as a final mind-blower, the vehicle is running a transmission from a\nMazda RX-7.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Science and Technology",
      "Lifestyle and Leisure",
      "Human Interest"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "aono",
          "sentiment": "none"
        },
        {
          "name": "larry chen",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "sema",
          "sentiment": "none"
        },
        {
          "name": "formula drift og taka aono",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-01-06T02:06:44.937+02:00",
    "updated": "2024-01-06T02:06:44.937+02:00"
  },
  {
    "uuid": "4e08837c3e20dfce59ecc29a943e967e37cbf57c",
    "url": "https://www.manilatimes.net/2025/07/24/tmt-newswire/globenewswire/harju-elekter-group-financial-results-1-62025/2155202",
    "ord_in_thread": 0,
    "author": "The Manila Times",
    "published": "2025-07-24T04:23:00Z",
    "title": "Harju Elekter Group financial results, 1-6/2025 | The Manila Times",
    "text": "The second quarter and first half of 2025 were successful for the Harju Elekter in terms of results. Although we have seen a decline in revenue compared to previous periods, we have continued to improve profitability - a long-term strategic goal of the Group.\nThe Estonian production unit delivered the strongest performance in the first half-year, supported by continued high demand for substation solutions for distribution networks as well as for more complex E-house type solutions used in data centres. A notable result was also achieved by the Finnish subsidiary Telesilta OY, which specializes in the design and installation of electrical solutions for the shipbuilding industry.\nWhile the results of the Lithuanian, Finnish, and Swedish production units were more modest, the growth in order books in these units indicates increased customer interest and readiness to launch new projects - a development expected to have a positive impact in the second half of the year and into 2026. Although interest in industrial automation and energy efficiency solutions has remained stable or grown, the industrial sector as a whole remains under pressure - primarily due to high input prices and weak export performance, both of which continue to affect our key target markets where investment activity has been cautious.\nOverall, we expect strong financial results for the full year 2025. This outlook is supported by declining interest rates, which have improved the investment climate and contributed to a more active economic environment.\nIn April, AS Harju Elekter Group’s Finnish subsidiary Harju Elekter OY exited a financial investment by divesting a 9.15% stake in IGL Technologies OY, a leading Finnish developer and operator of parking and e-mobility solutions. This move aligns with the Group’s strategy to focus on core operations and direct more resources toward product development and innovation - particularly the development of next-generation chargers that meet the growing demand for sustainable and smart energy solutions.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Economy, Business and Finance",
      "Social Issue",
      "Human Interest"
    ],
    "topics": [
      "Economy, Business and Finance->financial service",
      "Economy, Business and Finance->business reporting and performance",
      "Social Issue->social condition",
      "Social Issue->demographics"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "internal_images": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": [
        {
          "name": "Harju Elekter Group",
          "sentiment": "negative",
          "tickers": []
        },
        {
          "name": "Telesilta OY",
          "sentiment": "none",
          "tickers": []
        }
      ]
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": null,
      "top_news": [
        "top_news_ph",
        "top_news"
      ],
      "bias": "center",
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-07-24T07:52:02.704+03:00",
    "updated": "2025-07-25T08:09:06.000+03:00"
  },
  {
    "uuid": "3cdf9f4798a8deb30b267b0cc26fa71a64c0a0f4",
    "url": "https://www.telemundo.com/noticias/noticias-telemundo-mediodia/estados-unidos/video/el-video-de-una-empleada-de-taco-bell-salvando-una-bebe-que-dejo-de-respirar-tmvo12629526",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "TELEMUNDO",
    "published": "2024-04-18T21:14:00Z",
    "title": "El video de una empleada de Taco Bell salvando a una bebé que dejó de respirar | Telemundo",
    "text": "- UP NEXT Con dos eventos el príncipe William retoma sus actividades públicas01:28 Video del día: Dan la bienvenida a una cría de rinoceronte blanco, una especie amenazada00:37 Una madre entra en trabajo de parto en plena caravana migrante en México00:36 Ordenan la evacuación de una isla entera por la amenaza de un volcán00:31 Sigue el tiempo severo y el mayor peligro se reporta en Texas por el granizo00:33 Ya hay nueve acusados por el espectacular robo de 6,600 lingotes de oro de un aeropuerto00:34 No acusan al policía que mató a una joven porque no podían probarle algo \"mas allá de una duda razonable\"01:54 Podrían compensar a las víctimas de Nassar porque el FBI cometió \"errores fundamentales\" en el caso00:27 Una hermana de Robert Kennedy Jr. encabezará el apoyo de su familia a la reelección de Biden00:36 Schumer dice que pararon en seco el 'impeachment' a Mayorkas para que no se use como arma política00:25 Dicen que fallas del 911 no fueron por ataques cibernéticos. Hace poco el Gobierno alertó sobre ello02:26 \"No es típico\" que jurados pidan ser excusados pero ocurrió en el juicio de Trump porque \"es único\"03:29 Ya son dos los jurados de Trump que fueron retirados del juicio. Son una enfermera y un ingeniero00:37 Noticias Mediodía 04/20 El video de la euforia de una latina al saber que fue aceptada en Yale (adonde dudó en aplicar)04:12 Faltan 100 días para los Juegos Olímpicos y aquí le damos cinco claves que le pueden interesar03:04 Una inusual tormenta causa destrucción y muerte en Dubai00:37 El tiempo severo causa estragos en Iowa y otras zonas del Medio Oeste del país00:30 EE.UU. registra un número récord de nuevos emprendedores. La mitad son mujeres00:43 Un juez le dijo a 'El Chapo' que no es él quien puede cambiar las condiciones de su confinamiento00:27 - UP NEXT Con dos eventos el príncipe William retoma sus actividades públicas01:28 Video del día: Dan la bienvenida a una cría de rinoceronte blanco, una especie amenazada00:37 Una madre entra en trabajo de parto en plena caravana migrante en México00:36 Ordenan la evacuación de una isla entera por la amenaza de un volcán00:31 Sigue el tiempo severo y el mayor peligro se reporta en Texas por el granizo00:33 Ya hay nueve acusados por el espectacular robo de 6,600 lingotes de oro de un aeropuerto00:34 No acusan al policía que mató a una joven porque no podían probarle algo \"mas allá de una duda razonable\"01:54 Podrían compensar a las víctimas de Nassar porque el FBI cometió \"errores fundamentales\" en el caso00:27 Una hermana de Robert Kennedy Jr. encabezará el apoyo de su familia a la reelección de Biden00:36 Schumer dice que pararon en seco el 'impeachment' a Mayorkas para que no se use como arma política00:25 Dicen que fallas del 911 no fueron por ataques cibernéticos. Hace poco el Gobierno alertó sobre ello02:26 \"No es típico\" que jurados pidan ser excusados pero ocurrió en el juicio de Trump porque \"es único\"03:29 Ya son dos los jurados de Trump que fueron retirados del juicio. Son una enfermera y un ingeniero00:37 Noticias Mediodía 04/20 El video de la euforia de una latina al saber que fue aceptada en Yale (adonde dudó en aplicar)04:12 Faltan 100 días para los Juegos Olímpicos y aquí le damos cinco claves que le pueden interesar03:04 Una inusual tormenta causa destrucción y muerte en Dubai00:37 El tiempo severo causa estragos en Iowa y otras zonas del Medio Oeste del país00:30 EE.UU. registra un número récord de nuevos emprendedores. La mitad son mujeres00:43 Un juez le dijo a 'El Chapo' que no es él quien puede cambiar las condiciones de su confinamiento00:27",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "positive",
    "categories": [
      "Human Interest"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-04-19T00:32:29.863+03:00",
    "updated": "2024-04-19T00:32:29.863+03:00"
  },
  {
    "uuid": "f0733b44a5fa5e39affbd101063af99d5f3439d3",
    "url": "https://www.xda-developers.com/dont-buy-intel-arrow-lake-cpu",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "xda-developers.com",
    "published": "2024-11-22T11:00:00Z",
    "title": "Don't buy an Intel Arrow Lake CPU, get one of these instead",
    "text": "Thread Your changes have been saved\nEmail is sent\nEmail has already been sent\nclose You’ve reached your account maximum for followed topics.\nManage Your List Follow Followed Follow with Notifications Follow Unfollow Share Facebook X LinkedIn Reddit Flipboard Copy link Email Link copied to clipboard\nIntel and AMD have been locked in a CPU arms race for decades, with no end in sight. In recent years, Intel has fallen behind, struggling to match the efficiency and cost-effectiveness of AMD's latest Ryzen processors. Intel hoped to reverse that trend with its new Arrow Lake chip family.\n&#x2715 Remove Ads While they looked promising on paper, the Arrow Lake CPUs aren't as impressive as we (and Intel) hoped they would be, and they've already shown some wrinkles that need to be ironed out. Currently, the Ryzen lineup is a better choice for PC builders, so if you're assembling a new rig, here are our recommendations for the best AMD CPUs to buy over Arrow Lake.\nBest AMD alternatives to an Arrow Lake CPU\nEditor's choice AMD Ryzen 7 9700X 9 / 10 $320 $359 Save $39 AMD's all-new Ryzen 7 9700X not only undercuts its predecessor, but it's more powerful and sips less electricity. 8 cores and 16 threads will ensure all your favorite games run as intended by the developers, and a 5.5 GHz boost speed will make easy work of heavier loads.\nPros Great all-around performance Incredibly efficient Ready for overclocking Competitively priced Cons Not the most powerful in this price range $359 at Newegg $320 at Amazon $359 at Best Buy The Ryzen 7 9700X is a stand-out CPU among AMD's Zen 5 CPU lineup. With a thermal design power rating of 65, this 8-core, 16-thread AM5 processor sets the gold standard for efficiency. Despite its low power draw, however, the Ryzen 7 9700X is a highly capable chip. It comes with a 3.8 GHz base clock out of the box, but with a 5.5 GHz boost clock speed, you've got plenty of wiggle room for overclocking.\nRelated AMD Ryzen 5 9600X and Ryzen 7 9700X review: The newly crowned kings of efficiency Your power supply will be twiddling its thumbs.\nIn our benchmark tests, the Ryzen 7 9700X handily outperformed numerous Intel chips that have more cores. That's despite only drawing about 88 watts of power from the AM5 socket. This highlights exactly where and why Intel is falling behind. Finally, wIth a 40MB cache, PCIe 5.0 support, and compatibility with the latest high-speed DDR5 RAM, the 9700X is a perfect choice for newer builds. It also represents a pretty good value at around $300 retail.\n&#x2715 Remove Ads\nBest value AMD Ryzen 5 8600G 8 / 10 The AMD Ryzen 5 8600G is an affordable APU with integrated graphics processing. This allows you to play games without a dedicated GPU with good results at 1080p.\nPros The best cheap gaming CPU Useful for gaming even without a GPU Energy efficient Cons Stock cooler struggles under load $229 at Amazon $229 at Newegg $210 at B&H $229 at Best Buy One of the main draws of AMD has always been the value it offers relative to the competition (which includes both Intel and Nvidia). If affordability is an important consideration for your build, then the Ryzen 5 8600G is our top pick for a budget-friendly AMD alternative to Arrow Lake. In fact, its built-in graphics processing is good enough that you may not even need to fork over the cash for a GPU at all.\nRelated AMD Ryzen 5 8600G review: The only affordable gaming CPU you should buy Amazing 1080p performance on a budget\nAlong with six cores and 12 threads, the Ryzen 5 8600G features AMD Radeon 760M integrated graphics. That means that this APU precludes the need for a discrete graphics card to play many games. Of course, you'll still need a dedicated GPU if you want to crank up the settings on the latest AAA games, but the Radeon 760M iGPU is powerful enough to deliver respectable performance for 1080p gaming. We were able to enjoy smooth performance even on demanding games like Cyberpunk 2077 and Elden Ring at 40-60 FPS. Not bad for a CPU that costs around $200. The bad news is that, despite its relatively modest 65 TDP rating, the Ryzen 5 8600G can run a bit hot and the stock cooler can't always keep up – but you should have plenty of money left over to get a good aftermarket cooler for it.\n&#x2715 Remove Ads\nPremium pick AMD Ryzen 9 9950X 8 / 10 With the same cores and threads as its predecessor, the AMD Ryzen 9 9950X is a powerful processor built on the new Zen 5 architecture. It's cheaper, doesn't run as hot, and sucks less power from the motherboard, resulting in an efficient flagship CPU.\nPros Powerful 16-core performance Efficient Zen 5 architecture Cheaper than its predecessor Cons There are better options for gaming $600 at Newegg $672 at Amazon If money's no object, however, then the Ryzen 9 9950X ranks high among the cream of AMD's Zen 5 crop. This flagship CPU packs 16 cores, 32 threads, and a boost clock speed of 5.7 GHz, delivering plenty of muscle for enthusiast-tier PC builds. The 9950X was one of the highest-performing chips in our stress tests, consistently outpacing all but the highest-end Core i9 CPUs in multi-core benchmarks. However, it out-performed, or at least matched, pretty much everything in the single-core tests.\nRelated AMD Ryzen 9 9900X and 9950X review: Cool, fast, and powerful The best Zen 5 has to offer.\n1 Even better is that, due to its newer Zen 5 architecture, the Ryzen 9 9950X delivers that beastly performance while drawing about 50 fewer watts than its predecessor, the 7950X. This, again, shows the strides that AMD is making when it comes to energy efficiency. If we have one caveat about the 9950X, it's that this CPU isn't the best choice for a high-end gaming build. It's tailored more towards workstation PCs, although there's no reason it can't sit inside a gaming PC – our next pick is simply a better option for that.\n&#x2715 Remove Ads\nBest for gaming AMD Ryzen 7 9800X3D 9 / 10 The AMD Ryzen 7 9800X3D is the first 9000 series CPU from AMD with its 3D V-Cache technology, offering plenty of cache for storing data on the chip rather than slower RAM. It's an ideal pick for a high-end gaming PC with the latest and greatest from AMD, Intel, and Nvidia.\nPros Superb gaming performance Good value for high-end builds Excellent 3D V-Cache technology Efficient for its power Cons Can still run hot $479 at Amazon $479 at Newegg $479 at AMD Ryzen 7 9800X3D is another shining star in AMD's 2024 lineup, and it's currently our favorite gaming CPU by a country mile. You might not think that your choice of CPU is the most important part of a gaming build, and you're not wrong – after all, unless you're running with an APU, your graphics card does most of the heavy lifting when it comes to running the latest games at high settings and resolutions. Your processor shouldn't be an afterthought, however. If you're putting together a high-end gaming PC, the Ryzen 7 9800X3D is definitely the CPU to get.\nRelated AMD Ryzen 7 9800X3D review: Why would you buy any other CPU for gaming? Playing around with AMD's first Zen 5 X3D gaming CPU.\nThe 9800X3D is a beefy 8-core, 16-thread CPU in its own right, but what makes it stand out for gaming is AMD's innovative 3D V-Cache technology. This puts a massive 104MB cache right on the chip, so it doesn't have to use the slower RAM for caching. Its updated Zen 5 architecture lets it deliver excellent performance with a 120 TDP rating (drawing around 150 watts from the AM5 socket), which is impressive. That said, it can still run a bit hot under load, so consider getting a top-notch cooler for it. But even with that potential added expense, the Ryzen 7 9800X3D still comes in cheaper than our premium pick with an MSRP of $479.\n&#x2715 Remove Ads\nBest APU AMD Ryzen 7 8700G 9 / 10 $279 $329 Save $50 AMD's Ryzen 7 8700G is a powerful APU with integrated processing and graphics, negating the need for a discrete GPU. It's powerful enough for 1080p and 1440p gaming.\nPros Great 1080p gaming performance Attractive price Perfect for budget gaming builds Cons Won't handle 1440p at high settings $329 at Amazon $279 at Newegg $329 at Best Buy APUs are perhaps one of AMD's best innovations. These chips combine CPU and GPU cores onto a single die. While that's not a novelty in 2024 (just look at Apple's M-series silicon chips), AMD was among the first to do it. The term \"APU\" has been retired, but the technology remains, and the Ryzen 7 8700G is one of the best examples of it. This 8-core 16-thread AM5 CPU is similar to our value pick, the Ryzen 5 8600G, but with better specs. Most notably, it sports a more powerful Radeon 780M iGPU. This allows it to easily handle modern games at 1080p, although we were able to bump up the resolution to 1440p for many titles with some adjustments to the settings.\nRelated AMD Ryzen 7 8700G review: The best gaming CPU for those on a budget Farewell, discrete graphics card\nTemperatures were also very stable even with the stock cooler, barely exceeding 80C even under heavy loads. The Ryzen 7 8700G is simply one of the best APUs AMD has made to date and is a great choice for budget-friendly gaming builds or any other setup that doesn't need a discrete GPU. If you're set on 1440p gaming at high settings, though, you're still better off with a dedicated graphics card. But for around 300 bucks, we really can't find much to complain about with the 8700G.\n&#x2715 Remove Ads\nBest Zen 3 CPU AMD Ryzen 5 5600X The AMD Ryzen 5 5600X is our pick for the best overall CPU if you're leaning towards an AMD-based build. It's not as powerful as the Ryzen 9 5950X, but it's way cheaper and it beats nearly all the Intel chips in its category and beyond.\nPros Dirt cheap Still readily available Great thermal efficiency Cons No integrated graphics $126 at Amazon $299 at Best Buy $134 at Newegg Although the Zen 5 CPUs have just hit the market and Zen 4 remains the go-to standard for AMD builds, there are still some Zen 3 chips worth looking at if your needs are modest. If you're looking to go even cheaper than our value pick, or if you're just upgrading an older system that's not compatible with a Zen 4 or Zen 5 CPU for whatever reason, the Ryzen 5 5600X is a worthy prior-gen option. It's a couple years old now, but the 5600X is a capable (and cheap!) AM4 processor.\nRelated AMD Ryzen 5 5600X vs Intel Core i5-12600K: The best mainstream CPU In this article, we'll take a look at the AMD Ryzen 5 5600X vs the Intel Core i5-12600K comparison to see which one's a better CPU.\nThe Ryzen 5 5600X packs six cores and 12 threads with a boost frequency of up to 4.6GHz, delivering mid-range performance for a basement-level price. This chip is readily available for less than $150. It's a no-brainer for cheap builds or older systems in need of an upgrade. Its excellent thermal efficiency and 65 TDP rating ensure that you won't need a complicated cooling setup, either. Just bear in mind that the 5600X has no integrated graphics, so you'll need to pair it with a GPU, regardless of whether it's sitting inside a gaming PC or not.\n&#x2715 Remove Ads We can't recommend Intel Arrow Lake CPUs (yet) We can't deny that Intel is putting the work in with its new Arrow Lake CPUs, but in our analysis, they need some more time in the oven before they're ready for prime time. Although they're capable chips, the Arrow Lake processors are already having some problems. Intel is working to iron out these wrinkles, and we're confident they'll succeed. But until they do, and we're confident these problems are in the rearview, it's hard for us to recommend these CPUs from a reliability perspective.\nThat means that if you're building a PC and you're not married to Intel, stick with Ryzen for the moment. AMD's CPUs still outflank Intel when it comes to value and energy efficiency, and regardless of what your budget or build goals are, there's a Ryzen chip to fit. Our top recommendation is the Ryzen 7 9700X, which is a fantastic all-around processor for most builds. It's not just the best alternative to Arrow Lake, it's the best CPU, period, which is why it earned the top spot on our roundup of the best CPUs of 2024 .\n&#x2715 Remove Ads Of course, you have plenty of others to choose from. If you're on a budget, consider the Ryzen 5 8600G. Our value pick is an APU, meaning it combines CPU and GPU cores onto a single chip. It's good to go for work and gaming, even without a discrete graphics card. On the other side of the price spectrum sits our premium pick, the Ryzen 9 9950X. This beastly CPU is the perfect choice for beefy workstations. The Ryzen 7 9800X3D is another premium choice tailored for enthusiast gaming builds. Whatever your needs are, AMD has a CPU to fit. Give Intel Arrow Lake a pass, at least for now.\nEditor's choice AMD Ryzen 7 9700X 9 / 10 $320 $359 Save $39 AMD's all-new Ryzen 7 9700X not only undercuts its predecessor, but it's more powerful and sips less electricity. 8 cores and 16 threads will ensure all your favorite games run as intended by the developers, and a 5.5 GHz boost speed will make easy work of heavier loads.\n$359 at Newegg $320 at Amazon $329 at AMD $359 at Best Buy CPU AMD Zen 5: Everything to know about AMD's next-gen CPU architecture Your changes have been saved\nEmail is sent\nEmail has already been sent\nclose You’ve reached your account maximum for followed topics.\nManage Your List Follow Followed Follow with Notifications Follow Unfollow Readers like you help support XDA. When you make a purchase using links on our site, we may earn an affiliate commission. Read More . Close",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Science and Technology"
    ],
    "ai_allow": true,
    "canonical": false,
    "webz_reporter": false,
    "external_links": [
      "http://www.amazon.com/exec/obidos/ASIN/B08166SLDF",
      "https://www.valnetinc.com/en/terms-of-use#community-guidelines",
      "https://www.valnetinc.com/",
      "https://shop-us-en.amd.com/amd-ryzen-7-9700x-processor/",
      "https://shop-links.co/link/?exclusive=1&publisher_slug=xda&article_name=Don%27t+buy+an+Intel+Arrow+Lake+CPU%2C+get+one+of+these+instead&article_url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&u1=UUxdaUeUpU1014629&url=https%3A%2F%2Fwww.bestbuy.com%2Fsite%2Famd-ryzen-5-8600g-6-core-12-thread-4-3-ghz-5-0-ghz-max-boost-socket-am5-unlocked-desktop-processor%2F6573532.p%3FskuId%3D6573532",
      "https://static1.xdaimages.com/wordpress/wp-content/uploads/wm/2023/06/ocpc-ak-mod-4.JPG?q=49&fit=crop&w=360&h=240&dpr=2",
      "https://redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-9-9950x-4-3-ghz-16-core-am5-170w-processor-100-100001277wof%2Fp%2FN82E16819113841%3FItem%3DN82E16819113841",
      "https://www.bhphotovideo.com/c/product/1804827-REG/amd_100_100001237box_ryzen_5_8600g_wraith.html/BI/21019/KBID/17612/SID/UUxdaUeUpU1014629",
      "https://xdaforums.com/",
      "https://www.valnetinc.com/en/privacy-policy",
      "https://www.valnetinc.com/en/terms-of-use",
      "https://redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-7-8700g-ryzen-7-7000-series%2Fp%2FN82E16819113811",
      "https://redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-7-9800x3d-ryzen-7-9000-series-granite-ridge-zen-5-socket-am5-processor%2Fp%2FN82E16819113877",
      "https://t.me/xdadevelopershub",
      "https://shop-links.co/link/?exclusive=1&publisher_slug=xda&article_name=Don%27t+buy+an+Intel+Arrow+Lake+CPU%2C+get+one+of+these+instead&article_url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&u1=UUxdaUeUpU1014629&url=https%3A%2F%2Fwww.bestbuy.com%2Fsite%2Famd-ryzen-7-9700x-8-core-processor-radeon-graphics-8-core-16-thread-65w-am5-40mb-silver%2F6589136.p%3FskuId%3D6589136",
      "https://discord.gg/e4v8qtkcBw",
      "http://www.amazon.com/exec/obidos/ASIN/B0D6NNRBGP",
      "https://www.reddit.com/submit?url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F",
      "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F%2F&src=sdkpreparse",
      "https://web.whatsapp.com/send?text=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F",
      "https://redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-7-9700x-3-8-ghz-8-core-am5-65w-processor-100-100001404wof%2Fp%2FN82E16819113843",
      "http://www.amazon.com/exec/obidos/ASIN/B0CQ4JBKW3",
      "http://www.amazon.com/exec/obidos/ASIN/B0CQ4GYTTX",
      "https://static1.xdaimages.com/wordpress/wp-content/uploads/wm/2023/06/ocpc-ak-mod-4.JPG",
      "https://twitter.com/xdadevelopers",
      "https://www.instagram.com/xdasocial/",
      "http://share.flipboard.com/bookmarklet/popout?v=2&title=Don%27t%20buy%20an%20Intel%20Arrow%20Lake%20CPU%2C%20get%20one%20of%20these%20instead&url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&utm_campaign=tools&utm_medium=article-share&utm_source=www.xda-developers.com",
      "https://www.valnetinc.com/en/editorial-integrity",
      "http://www.amazon.com/exec/obidos/ASIN/B0D6NMDNNX",
      "https://redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-5-8600g-ryzen-5-8000-series%2Fp%2FN82E16819113814",
      "http://www.amazon.com/exec/obidos/ASIN/B0DKFMSMYK",
      "https://twitter.com/intent/tweet?text=Don%27t%20buy%20an%20Intel%20Arrow%20Lake%20CPU%2C%20get%20one%20of%20these%20instead&url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F",
      "https://redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-5-5600x%2Fp%2FN82E16819113666",
      "https://shop-links.co/link/?exclusive=1&publisher_slug=xda&article_name=Don%27t+buy+an+Intel+Arrow+Lake+CPU%2C+get+one+of+these+instead&article_url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&u1=UUxdaUeUpU1014629&url=https%3A%2F%2Fwww.bestbuy.com%2Fsite%2Famd-ryzen-5-5600x-4th-gen-6-core-12-threads-unlocked-desktop-processor-with-wraith-stealth-cooler%2F6438943.p%3FskuId%3D6438943",
      "https://shop-us-en.amd.com/amd-ryzen-7-9800x3d-processor/",
      "https://www.facebook.com/xda.developers",
      "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&title=Don%27t%20buy%20an%20Intel%20Arrow%20Lake%20CPU%2C%20get%20one%20of%20these%20instead&source=www.xda-developers.com&summary=Intel%27s%20new%20Arrow%20Lake%20CPUs%20are%20here%2C%20but%20they%27re%20not%20quite%20ready%20for%20prime%20time.%20If%20you%27re%20building%20a%20PC%20now%2C%20check%20out%20these%20CPUs%20instead.",
      "https://shop-links.co/link/?exclusive=1&publisher_slug=xda&article_name=Don%27t+buy+an+Intel+Arrow+Lake+CPU%2C+get+one+of+these+instead&article_url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&u1=UUxdaUeUpU1014629&url=https%3A%2F%2Fwww.bestbuy.com%2Fsite%2Famd-ryzen-7-8700g-8-core-16-thread-4-2-ghz-5-1-ghz-max-boost-socket-am5-unlocked-desktop-processor%2F6573531.p%3FskuId%3D6573531",
      "https://static1.xdaimages.com/wordpress/wp-content/uploads/wm/2023/06/ocpc-ak-mod-4.JPG?q=49&fit=crop&w=420&h=260&dpr=2",
      "https://www.youtube.com/user/xdadevelopers?sub_confirmation=1",
      "https://www.redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-5-5600x%2Fp%2FN82E16819113666",
      "https://valnetinc.com/en/editorial-integrity",
      "http://share.flipboard.com/bookmarklet/popout",
      "https://www.youtube.com/user/xdadevelopers",
      "http://amazon.com/exec/obidos/ASIN/B0D6NMDNNX",
      "https://linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&title=Don%27t%20buy%20an%20Intel%20Arrow%20Lake%20CPU%2C%20get%20one%20of%20these%20instead&source=www.xda-developers.com&summary=Intel%27s%20new%20Arrow%20Lake%20CPUs%20are%20here%2C%20but%20they%27re%20not%20quite%20ready%20for%20prime%20time.%20If%20you%27re%20building%20a%20PC%20now%2C%20check%20out%20these%20CPUs%20instead.",
      "https://facebook.com/xda.developers",
      "https://reddit.com/submit?url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F",
      "https://www.t.me/xdadevelopershub",
      "https://www.shop-links.co/link/?exclusive=1&publisher_slug=xda&article_name=Don%27t+buy+an+Intel+Arrow+Lake+CPU%2C+get+one+of+these+instead&article_url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&u1=UUxdaUeUpU1014629&url=https%3A%2F%2Fwww.bestbuy.com%2Fsite%2Famd-ryzen-5-8600g-6-core-12-thread-4-3-ghz-5-0-ghz-max-boost-socket-am5-unlocked-desktop-processor%2F6573532.p%3FskuId%3D6573532",
      "https://facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F%2F&src=sdkpreparse",
      "https://youtube.com/user/xdadevelopers?sub_confirmation=1",
      "https://valnetinc.com/en/privacy-policy",
      "https://valnetinc.com/en/terms-of-use",
      "https://www.redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-7-8700g-ryzen-7-7000-series%2Fp%2FN82E16819113811",
      "https://www.twitter.com/intent/tweet?text=Don%27t%20buy%20an%20Intel%20Arrow%20Lake%20CPU%2C%20get%20one%20of%20these%20instead&url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F",
      "https://bhphotovideo.com/c/product/1804827-REG/amd_100_100001237box_ryzen_5_8600g_wraith.html/BI/21019/KBID/17612/SID/UUxdaUeUpU1014629",
      "https://www.static1.xdaimages.com/wordpress/wp-content/uploads/wm/2023/06/ocpc-ak-mod-4.JPG",
      "https://www.valnetinc.com",
      "http://amazon.com/exec/obidos/ASIN/B08166SLDF",
      "https://www.reddit.com/submit",
      "https://www.static1.xdaimages.com/wordpress/wp-content/uploads/wm/2023/06/ocpc-ak-mod-4.JPG?q=49&fit=crop&w=420&h=260&dpr=2",
      "https://twitter.com/intent/tweet",
      "https://www.redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-7-9800x3d-ryzen-7-9000-series-granite-ridge-zen-5-socket-am5-processor%2Fp%2FN82E16819113877",
      "https://www.discord.gg/e4v8qtkcBw",
      "https://www.twitter.com/xdadevelopers",
      "https://www.redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-7-9700x-3-8-ghz-8-core-am5-65w-processor-100-100001404wof%2Fp%2FN82E16819113843",
      "https://redirect.viglink.com/",
      "https://shop-us-en.amd.com/amd-ryzen-7-9700x-processor",
      "http://www.share.flipboard.com/bookmarklet/popout?v=2&title=Don%27t%20buy%20an%20Intel%20Arrow%20Lake%20CPU%2C%20get%20one%20of%20these%20instead&url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&utm_campaign=tools&utm_medium=article-share&utm_source=www.xda-developers.com",
      "https://www.shop-us-en.amd.com/amd-ryzen-7-9800x3d-processor/",
      "https://www.redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-5-8600g-ryzen-5-8000-series%2Fp%2FN82E16819113814",
      "https://www.web.whatsapp.com/send?text=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F",
      "https://www.shop-links.co/link/?exclusive=1&publisher_slug=xda&article_name=Don%27t+buy+an+Intel+Arrow+Lake+CPU%2C+get+one+of+these+instead&article_url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&u1=UUxdaUeUpU1014629&url=https%3A%2F%2Fwww.bestbuy.com%2Fsite%2Famd-ryzen-5-5600x-4th-gen-6-core-12-threads-unlocked-desktop-processor-with-wraith-stealth-cooler%2F6438943.p%3FskuId%3D6438943",
      "https://www.facebook.com/sharer/sharer.php",
      "http://amazon.com/exec/obidos/ASIN/B0CQ4JBKW3",
      "http://amazon.com/exec/obidos/ASIN/B0DKFMSMYK",
      "https://web.whatsapp.com/send",
      "https://static1.xdaimages.com/wordpress/wp-content/uploads/wm/2023/06/ocpc-ak-mod-4.JPG",
      "https://xdaforums.com",
      "https://valnetinc.com/en/terms-of-use#community-guidelines",
      "https://instagram.com/xdasocial/",
      "https://www.redirect.viglink.com/?key=f246be432ee335db8d1b13f098db73cc&cuid=UUxdaUeUpU1014629&u=https%3A%2F%2Fwww.newegg.com%2Famd-ryzen-9-9950x-4-3-ghz-16-core-am5-170w-processor-100-100001277wof%2Fp%2FN82E16819113841%3FItem%3DN82E16819113841",
      "http://amazon.com/exec/obidos/ASIN/B0CQ4GYTTX",
      "https://www.xdaforums.com/",
      "https://www.shop-us-en.amd.com/amd-ryzen-7-9700x-processor/",
      "https://shop-us-en.amd.com/amd-ryzen-7-9800x3d-processor",
      "http://amazon.com/exec/obidos/ASIN/B0D6NNRBGP",
      "https://www.shop-links.co/link/?exclusive=1&publisher_slug=xda&article_name=Don%27t+buy+an+Intel+Arrow+Lake+CPU%2C+get+one+of+these+instead&article_url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&u1=UUxdaUeUpU1014629&url=https%3A%2F%2Fwww.bestbuy.com%2Fsite%2Famd-ryzen-7-9700x-8-core-processor-radeon-graphics-8-core-16-thread-65w-am5-40mb-silver%2F6589136.p%3FskuId%3D6589136",
      "https://www.linkedin.com/shareArticle",
      "https://www.instagram.com/xdasocial",
      "https://valnetinc.com/",
      "https://shop-links.co/link/",
      "https://www.static1.xdaimages.com/wordpress/wp-content/uploads/wm/2023/06/ocpc-ak-mod-4.JPG?q=49&fit=crop&w=360&h=240&dpr=2",
      "https://www.shop-links.co/link/?exclusive=1&publisher_slug=xda&article_name=Don%27t+buy+an+Intel+Arrow+Lake+CPU%2C+get+one+of+these+instead&article_url=https%3A%2F%2Fwww.xda-developers.com%2Fdont-buy-intel-arrow-lake-cpu%2F&u1=UUxdaUeUpU1014629&url=https%3A%2F%2Fwww.bestbuy.com%2Fsite%2Famd-ryzen-7-8700g-8-core-16-thread-4-2-ghz-5-1-ghz-max-boost-socket-am5-unlocked-desktop-processor%2F6573531.p%3FskuId%3D6573531"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "Lucas Coll",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "Intel",
          "sentiment": "negative"
        },
        {
          "name": "Lenovo Microsoft",
          "sentiment": "none"
        },
        {
          "name": "AMD",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-11-22T13:42:09.170+02:00",
    "updated": "2024-11-22T16:40:19.680+02:00"
  },
  {
    "uuid": "6aa0424fc830ed79bd00192b01d0f4ea8546a7a7",
    "url": "https://newsable.asianetnews.com/world/football-how-messi-magic-saved-90-year-old-argentine-woman-during-hamas-oct-7-attack-on-israel-watch-snt-sa0y6r",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Team Asianet Newsable",
    "published": "2024-03-08T07:53:00Z",
    "title": "How 'Messi magic' saved 90-year-old Argentine woman during Hamas' Oct 7 attack on Israel (WATCH)",
    "text": "In an upcoming documentary, a 90-year-old Argentine woman is set to narrate what happened on the fateful day of October 7 2023 when Hamas launched a massive attack in Israel and how 'Messi' magic saved her life. On October 7, 2023, when Hamas terrorists burst into a 90-year-old woman's home in Israel's Kibbutz Nir Oz, Esther Cunio did the unthinkable. The elderly woman discussed her Argentine heritage and the fact that she was born in legendary footballer Lionel Messi's home nation. Surprisingly, 'Messi' did the magic for Esther. Not only did she make it through the attack, but she even posed for a brief video with a Hamas gunman while he was holding his assault rifle. The Times of Israel reported that eight members of her extended family were captured during the Hamas attack, which led to a large-scale ground assault by the Israel Defense Forces (IDF). The rest of her family was freed as part of the peace agreement, but her two grandkids and one of their partners remain detained in Gaza. Five months since the attack by the Palestinian terrorist group, Esther Cunio is set to feature in a brand-new documentary on the horrifying assault that started the current conflict in Gaza. Five months on, Cunio is set to feature in a new documentary on the Hamas attack that prompted the ongoing war in Gaza. In a clip from the documentary \"Voces de 7 de octubre - Latino Stories of Survival\" which is still in the making, the 90-year-old woman narrated what had happened on that fateful day. On October 7, Cunio recalled in the film, two Hamas terrorists knocked on her door and asked about her family. Her life was soon saved by an unexpected turn of events in the conversation. \"Do you watch football?\" she asked them. To a nod from a Hamas gunman, she replied, \"I am from where Messi is from.\" \"I like Messi,\" said one of them, brimming with excitement upon hearing the name of Argentina's 2022 World Cup winning captain. Then, for a video, he had her strike a stance with his gun and a victory sign. Recounting the encounter in the upcoming documentary, she hoped Messi would realize that she made it through that day because of the Inter Miami star and former Barcelona legend.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "War, Conflict and Unrest"
    ],
    "external_links": [
      "https://twitter.com/share?text=How%20",
      "https://news.google.com/publications/CAAqBwgKMMjjzwsw9_7mAw?hl=en-IN&gl=IN&ceid=IN:en",
      "https://news.google.com/publications/CAAqBwgKMMjjzwsw9_7mAw",
      "https://twitter.com/share",
      "https://www.twitter.com/share?text=How%20",
      "https://www.news.google.com/publications/CAAqBwgKMMjjzwsw9_7mAw?hl=en-IN&gl=IN&ceid=IN:en"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "messi",
          "sentiment": "negative"
        },
        {
          "name": "esther cunio",
          "sentiment": "none"
        },
        {
          "name": "esther",
          "sentiment": "none"
        },
        {
          "name": "lionel messi",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "hamas",
          "sentiment": "negative"
        },
        {
          "name": "kibbutz nir oz",
          "sentiment": "none"
        },
        {
          "name": "times of israel",
          "sentiment": "none"
        },
        {
          "name": "israel defense forces",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "israel",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-03-08T12:25:24.033+02:00",
    "updated": "2024-03-09T08:57:58.472+02:00"
  }
]